US equities |
NVDA $239.57 ▲+2.40% SPCX $169.67 ▲+6.74% MU $1,062.47 ▼-1.16% TSLA $379.64 ▲+2.44% SNDK $1,698.00 ▼-1.28% MSFT $528.71 ▲+2.16% INTC $116.25 ▼-2.59% META $744.03 ▲+2.19%
FinancialContent

Latest News about Ophthalmic

Recent news which mentions Ophthalmic

IVIEW Therapeutics Inc. Announces Dosing of First Patient in Phase 1/2 Clinical Trial of IVW-1001 for Dry Eye Disease
Tags Conjunctivitis Eyelid Wipe Science
From PRLog